Viruses accumulate mutations as they replicate in infected cells. Repeated replication can lead to viral strains that show attenuated virulence. Such strains may act as vaccines if the attenuated virus can produce immunity without serious disease.
the reproduction of covid cells. sophia tran thomson has this report. the jararacussu pit viper is one of the deadliest snakes in south america. the viper s venom has enough potency to kill 16 people, but the dangerous snake could potentially help scientists develop a drug to combat coronavirus. researchers have found that the molecule peptide produced by the jararacussu pit viper inhibited the virus s ability to multiply in the cells of monkeys by 75%. translation: we were able to see that the peptides not only inhibited | the development of the virus in vitro, inside the cell, but we were also able to see that it was able to inhibit one of the proteins that is very important for the development of the virus and propagation of new viruses. and the peptides can be synthesised in a lab, making the capture or breeding of the snakes unnecessary.
translation: we are afraid that people will go hunting for the snakes all over brazil, thinking it will save the world, themselves or their family. that is not the case. is this an important discovery? without a doubt, it is. but chasing after the animal is not how it will be resolved. the component that was discovered is just a fraction from inside the venom. it is not the venom itself that will cure coronavirus. researchers will next test the efficiency of different doses of the molecule and whether it is able to prevent the virus from entering cells. but it will be a slow testing process and so far, there is no timeline on when human testing will begin. it s just four weeks until the uk premiere of daniel craig s fifth and final outing as james bond in no time to die , which has been repeatedly delayed by the pandemic. the final trailer has just been released and it shows
hydroxychloroquine, ivermectin work at preventing severe disease.ds the data, i am a data person i stick behind my evidence-based medicine academia. the jury is out when it comes to hydroxychloroquine i don t know if i m convinced yet and may be an appropriate setting and might be able to present but ivermectin a lot of studies still ongoing. it has an ability to decrease viral load in vitro. how it translates into larger settings, we don tt know yet but with that said, we need to continue our search for evidence based medicine for the treatment. but i can say, sean, these vaccines over 160 million americans fully vaccinated has clearly and drastically uncoupled severe disease from these cases. so while i don t think the vaccine is for everyone, it is a conversation between doctors and patients. i do think there is a lot of evidence showing that vaccines can reduce the risk of severe disease.
Research has shown that procaine and procaine-hydrochloride can reduce replication of SARS-CoV-2 and influenza A viruses in infected cells and reduce the production of cytokines by the viruses, making them potentially useful for treating COVID-19.